Genetics drives a new stage in precision preventive medicine 03/03/2026 Healthcare Personalized medicine The integration of polygenic risk models based on genome-wide association studies (GWAS) enables healthcare... Partners - ADNTRO GENETICS SL
Catch up with Condalab: II Digital Cell Biology Conference 03/03/2026 Healthcare Advanced therapies Condalab invites you to the second edition of our Digital Cell Biology Conference, a free online event aimed at... Partners - CONDALAB
BCN HEALTH publishes a systematic review highlighting the substantial economic burden of p... 03/03/2026 Healthcare Despite advances in early detection, risk-adapted treatment, and precision oncology, the findings indicate that prostate... Partners - BCN Health
ProtoQSAR and the Institute of Medicinal Chemistry (IQM-CSIC) sign a collaboration agreeme... 23/02/2026 Healthcare Advanced therapies The collaboration combines IQM-CSIC’s expertise in compound design, synthesis, and biological evaluation with ProtoQSAR... Partners - ProtoQSAR
Basque Health Cluster and GSK promote an alliance to strengthen collaboration and innovati... 23/02/2026 Healthcare Access to innovation GSK joins the cluster as a Business Partner with a focus on connecting stakeholders, generating knowledge and... Partners - GSK
Click-CAR: Strategic Innovation for a New Generation of CAR-T Therapies 26/02/2026 Healthcare Advanced therapies The UTE BBZS_CAR-T consortium is advancing the CART_Andalucía project with a modular and scalable platform aimed at... Partners - Biotechnology Assets
BCN HEALTH has published 11 studies in 2025 and 2026 evaluating the incidence, productivit... 24/02/2026 Healthcare These studies have provided new, robust data to assist decision-makers in resource allocation and have offered deep... Partners - BCN Health
MSD becomes a healthcare partner of the Women's National Football Team 20/02/2026 Healthcare The aim of this alliance is to promote social awareness of human papillomavirus, the most common sexually transmitted... Partners - MSD
ORYZON receives European Medicines Agency approval to initiate a Phase II study of iadadem... 24/02/2026 Healthcare Innovative drugs Essential thrombocythemia is the most common type of myeloproliferative neoplasm (MPN) and is associated with an... Partners - Oryzon Genomics
The impact of digital twins on personalised medicine 20/02/2026 Healthcare Personalized medicine Digital twins make it possible to simulate personalised clinical scenarios without intervening directly on the patient... Partners - GENESIS Biomed
